| 18.10 BATS BZX Real-Time Price As of 10:50am ET |  +0.01 / +0.06%Today’s Change | 10.58 Today|||52-Week Range 31.80 | +27.92% Year-to-Date |
| Previous close | 18.09 |
| Today’s open | 18.11 |
| Day’s range | 18.01 - 18.27 |
| Volume | 110,792 |
| Average volume (3 months) | 985,413 |
| Market cap | $2.1B |
| Dividend yield | 5.53% |
| Earnings growth (last year) | +10.18% |
| Earnings growth (this year) | +91.00% |
| Earnings growth (next 5 years) | -167.64% |
| Revenue growth (last year) | +77.24% |
| P/E ratio | NM |
| Price/Sales | 188.03 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| INSYINSYS Therapeutics I... | -0.86 | -1.42% |
| ASPXAuspex Pharmaceutica... | -2.91 | -4.14% |
| RAREUltragenyx Pharmaceu... | -1.46 | -2.59% |
| IRWDIronwood Pharmaceuti... | -0.31 | -1.93% |
| Next reporting date | April 23, 2015 |
| EPS forecast (this quarter) | -$0.08 |
| Annual revenue (last year) | $8.4M |
| Annual profit (last year) | -$168.5M |
| Net profit margin | -871.93% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Michael W. Aguiar |
Senior Vice President- Operations Frank C. Pasqualone |
Corporate headquarters South San Francisco, California |
